PhotoCure ASA (FRA:PHS) Interest Expense: €-3.95 Mil (TTM As of Mar. 2026)

What is PhotoCure ASA Interest Expense?

PhotoCure ASA FRA:PHS -0.76% 75 Interest Expense is €-3.95 Mil as of Mar. 2026. GuruFocus rates FRA:PHS with a GF Score™ of 75/100 and a GF Value™ of €6.35 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. PhotoCure ASA's interest expense for the three months ended in Mar. 2026 was € -1.85 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was €-3.95 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. PhotoCure ASA's Operating Income for the three months ended in Mar. 2026 was € 10.81 Mil. PhotoCure ASA's Interest Expense for the three months ended in Mar. 2026 was € -1.85 Mil. PhotoCure ASA's Interest Coverage for the quarter that ended in Mar. 2026 was 5.84. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

PhotoCure ASA (FRA:PHS) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

PhotoCure ASA's Interest Expense for the three months ended in Mar. 2026 was €-1.85 Mil. Its Operating Income for the three months ended in Mar. 2026 was €10.81 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was €0.00 Mil.

PhotoCure ASA's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2026 )	/	Interest Expense (Q: Mar. 2026 )
	=	-1	*	10.808	/	-1.851
	=	5.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

PhotoCure ASA Interest Expense Historical Data

* Premium members only.

The historical data trend for PhotoCure ASA's Interest Expense can be seen below:

PhotoCure ASA Interest Expense Chart

PhotoCure ASA Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-2.35

-2.47

-2.29

-2.39

-2.09

PhotoCure ASA Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															-0.78	-0.86	-0.64	-0.61	-1.85

75GF Score

PhotoCure ASA FRA:PHS

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

PhotoCure ASA Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-3.95 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of €-3.95 Mil mean?

PhotoCure ASA (FRA:PHS) has a Interest Expense of €-3.95 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on PhotoCure ASA and its competitors.

Is PhotoCure ASA's Interest Expense too high?

PhotoCure ASA's current Interest Expense is €-3.95 Mil. Overall, PhotoCure ASA has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does PhotoCure ASA's Interest Expense compare to ZTS and UTHR?

PhotoCure ASA's Interest Expense of €-3.95 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Drug Manufacturers company?

A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on PhotoCure ASA and its competitors. PhotoCure ASA's current Interest Expense is €-3.95 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is PhotoCure ASA stock overvalued right now?

Based on GuruFocus' analysis, PhotoCure ASA (FRA:PHS) is currently considered Modestly Undervalued. The stock's GF Value™ is €6.35, compared to a current price of €5.19 — trading 18.3% below its estimated fair value. The current Interest Expense is €-3.95 Mil. PhotoCure ASA's overall GF Score™ is 75/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For PhotoCure ASA (FRA:PHS), the current Interest Expense is €-3.95 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PhotoCure ASA (FRA:PHS) Overvalued in 2026?

Based on GuruFocus' analysis, PhotoCure ASA stock appears to be undervalued. The current stock price of €5.19 is trading 18.3% below its estimated GF Value™ of €6.35. GuruFocus considers PhotoCure ASA to be Modestly Undervalued.

Key valuation signals for FRA:PHS:

Interest Expense: €-3.95 Mil
GF Value™: €6.35 vs. price of €5.19 (18.3% below fair value)
GF Score™: 75/100 with 1 warning sign

No single metric tells the full story. See the FRA:PHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PhotoCure ASA Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies OSL:VISTN XTER:MRK TSE:4502 XSWX:GALD SHSE:600276 NSE:SUNPHARMA XTAE:TEVA LSE:HLN XSWX:SDZ ZTS HKSE:03692 UTHR VTRS NSE:DIVISLAB OSTO:SOBI TSE:4507 NBIX NSE:TORNTPHARM XPAR:IPN SHSE:688506

Other Exchanges PHCUF:USA PHOO:Sweden PHO:Norway 0IMT:UK

Address Hoffsveien 4, Oslo, NOR, 0275

Website https://www.photocure.com

PhotoCure ASA is a Norway-based business group associated with the research, development, production, distribution, marketing, and sales of pharmaceutical products and specialty pharmaceutical companies. The technology platform of the company is focused on the field of photodynamic diagnosis and treatment of cancer. The company has two operating segments of the group the Commercial franchise and the Development portfolio. It generates prime revenue from the Commercial franchise segment, which includes Hexvix and Cysview products. Its geographical segments are Nordic countries, Germany, France, Austria, the United Kingdom, BeNeLux, Italy, Other European countries, Canada, and the United States.

75GF Score

Get the complete analysis for FRA:PHS

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.19

Price

€6.35

GF Value

View FRA:PHS Analysis

See Interest Expense data for all stocks →